Theravance Biopharma Inc.
(TBPH)
undefined
undefined%
At close: undefined
Balance Sheet (Annual)
Get detailed breakdowns of the balance-sheet with total debts,
total investments, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 |
| Cash & Equivalents | 39.55M | 298.17M | 89.96M | 81.47M | 58.06M | 378.02M | 88.98M | 344.71M | 112.71M | 89.22M | - | - |
| Short-Term Investments | 62.88M | 29.31M | 83.51M | 211.47M | 222.77M | 127.25M | 259.59M | 156.39M | 59.73M | 165.40M | - | - |
| Long-Term Investments | - | 836.00K | 67.54M | 12.75M | 4.99M | 11.87M | 41.59M | 91.56M | 50.86M | 51.40M | - | - |
| Other Long-Term Assets | 203.10M | 201.10M | 4.07M | 3.28M | 6.11M | 2.37M | 10.91M | 10.73M | 1.91M | -50.06M | 833.00K | -9.15M |
| Receivables | 17.47M | 16.79M | 57.60M | 69.67M | - | 10.67M | 9.36M | 9.72M | 37.15M | 2.13M | 1.13M | 941.00K |
| Inventory | - | 1.51M | 10.24M | 20.37M | 1.00 | 1.00 | 16.83M | 12.22M | 10.01M | 12.55M | 10.41M | 7.51M |
| Other Current Assets | 13.64M | 9.20M | 18.81M | 30.73M | 57.66M | 310.00K | 3.99M | 5.46M | 17.88M | 6.08M | 2.57M | 2.38M |
| Total Current Assets | 133.54M | 353.46M | 249.87M | 393.34M | 338.49M | 532.82M | 378.75M | 528.50M | 237.47M | 326.77M | 14.11M | 10.84M |
| Property-Plant & Equipment | 45.35M | 52.00M | 53.35M | 59.68M | 59.25M | 13.18M | 10.16M | 8.46M | 9.87M | 9.66M | 10.24M | 9.15M |
| Goodwill & Intangibles | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Long-Term Assets | 248.46M | 253.94M | 124.95M | 75.72M | 70.34M | 27.41M | 62.65M | 110.75M | 62.64M | 11.00M | 11.07M | 9.15M |
| Total Assets | 382.00M | 607.40M | 374.82M | 469.06M | 408.83M | 560.24M | 441.40M | 639.25M | 300.12M | 337.77M | 25.18M | 20.96M |
| Account Payables | 1.52M | 1.55M | 3.10M | 6.78M | 4.76M | 9.03M | 5.92M | 1.73M | 18.80M | 9.92M | 6.94M | 5.22M |
| Deferred Revenue | - | 24.00K | 98.00K | 11.52M | 31.57M | 43.40M | 125.00K | 152.00K | 144.00K | 89.00K | 8.21M | - |
| Short-Term Debt | 7.85M | 6.75M | 17.44M | 29.20M | -20.42M | - | - | - | - | - | - | - |
| Other Current Liabilities | 15.40M | 20.38M | 63.10M | 116.91M | 57.76M | 46.12M | 56.50M | 47.38M | 30.52M | 31.25M | 21.71M | 17.45M |
| Total Current Liabilities | 24.77M | 28.71M | 58.59M | 123.57M | 111.70M | 98.55M | 62.55M | 49.27M | 49.47M | 41.26M | 36.85M | 22.67M |
| Long-Term Debt | 90.47M | 90.81M | 652.08M | 647.06M | 492.92M | 454.35M | 223.75M | 222.68M | - | - | - | - |
| Other Long-Term Liabilities | 53.77M | 45.88M | 2.42M | 1.83M | 21.29M | 32.74M | 39.92M | 17.08M | 7.58M | 6.73M | 5.36M | - |
| Total Long-Term Liabilities | 144.24M | 136.88M | 654.80M | 649.24M | 520.96M | 513.27M | 263.67M | 239.75M | 7.58M | 6.73M | 5.36M | - |
| Total Liabilities | 169.00M | 165.60M | 713.39M | 772.81M | 632.67M | 611.82M | 326.22M | 289.02M | 57.05M | 47.98M | 42.21M | 22.67M |
| Total Debt | 49.16M | 74.12M | 652.08M | 647.06M | 492.92M | 454.35M | 223.75M | 222.68M | - | - | - | - |
| Common Stock | - | 1K | 1K | 1K | 1K | 1K | 1K | 1K | - | - | - | - |
| Retained Earnings | -909.10M | -853.91M | -1.73B | -1.53B | -1.25B | -1.01B | -797.74M | -512.23M | -321.56M | -139.34M | -17.04M | -6.99M |
| Comprehensive Income | -65.00K | -15.00K | -0.00 | 47.00K | 145.00K | -166.00K | -733.00K | -253.00K | -70.00K | -82.00K | - | - |
| Shareholders Equity | 213.00M | 441.80M | -338.57M | -303.75M | -223.84M | -51.59M | 115.18M | 350.23M | 243.06M | 289.79M | -17.04M | -6.99M |
| Total Investments | 62.88M | 29.31M | 151.04M | 224.22M | 227.75M | 139.12M | 301.17M | 255.95M | 110.59M | 216.79M | - | - |